Miglustat Improves Purkinje Cell Survival and Alters Microglial Phenotype in Feline Niemann-Pick Disease Type C
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Miglustat Improves Purkinje Cell Survival and Alters Microglial Phenotype in Feline Niemann-Pick Disease Type C
Authors
Keywords
-
Journal
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Volume 71, Issue 5, Pages 434-448
Publisher
Oxford University Press (OUP)
Online
2012-04-07
DOI
10.1097/nen.0b013e31825414a6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann-Pick disease type C after therapy with miglustat
- (2011) Simona Fecarotta et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Endosomal/Lysosomal Processing of Gangliosides Affects Neuronal Cholesterol Sequestration in Niemann-Pick Disease Type C
- (2011) Sharon Zhou et al. AMERICAN JOURNAL OF PATHOLOGY
- Anatomically Defined Neuron-Based Rescue of Neurodegenerative Niemann-Pick Type C Disorder
- (2011) M. E. Lopez et al. JOURNAL OF NEUROSCIENCE
- Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease
- (2011) Karen M. Ashe et al. PLoS One
- Treatment of cataplexy in Niemann–Pick disease type C with the use of miglustat
- (2010) Marcin Zarowski et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Niemann-Pick disease type C
- (2010) Marie T Vanier Orphanet Journal of Rare Diseases
- 2-Hydroxypropyl-β-Cyclodextrin Raises Hearing Threshold in Normal Cats and in Cats With Niemann-Pick Type C Disease
- (2010) Sarah Ward et al. PEDIATRIC RESEARCH
- Gangliosides in cell recognition and membrane protein regulation
- (2009) Pablo HH Lopez et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Long-Term Miglustat Therapy in Children With Niemann-Pick Disease Type C
- (2009) Marc C. Patterson et al. JOURNAL OF CHILD NEUROLOGY
- Neuropathology of the Mcoln1−/− Knockout Mouse Model of Mucolipidosis Type IV
- (2009) Matthew C. Micsenyi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Miglustat in patients with Niemann-Pick disease Type C (NP-C): A multicenter observational retrospective cohort study
- (2009) M. Pineda et al. MOLECULAR GENETICS AND METABOLISM
- Miglustat in adult and juvenile patients with Niemann–Pick disease type C: Long-term data from a clinical trial
- (2009) James E. Wraith et al. MOLECULAR GENETICS AND METABOLISM
- Clinical experience with miglustat therapy in pediatric patients with Niemann–Pick disease type C: A case series
- (2009) M. Pineda et al. MOLECULAR GENETICS AND METABOLISM
- Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression
- (2009) Cristin D. Davidson et al. PLoS One
- Substrate reduction therapy
- (2008) Frances M Platt et al. ACTA PAEDIATRICA
- Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease
- (2008) Yun-Ping Wu et al. HUMAN MOLECULAR GENETICS
- Treatment of a child diagnosed with Niemann–Pick disease type C with miglustat: A case report in Brazil
- (2008) M. L. F. Santos et al. JOURNAL OF INHERITED METABOLIC DISEASE
- 24 month-treatment with miglustat of three patients with Niemann-Pick disease type C: Follow up using brain spectroscopy
- (2008) Damien Galanaud et al. MOLECULAR GENETICS AND METABOLISM
- Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium
- (2008) Emyr Lloyd-Evans et al. NATURE MEDICINE
- Clinical, Electrophysiological, and Serum Biochemical Measures of Progressive Neurological and Hepatic Dysfunction in Feline Niemann-Pick Type C Disease
- (2008) Charles H Vite et al. PEDIATRIC RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started